腎細胞がん:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Cell Carcinoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Cell Carcinoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Cell Carcinoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Cell Carcinoma 25
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in Renal Cell Carcinoma Therapeutics Clinical Trials 37
Prominent Drugs 39
Latest Clinical Trials News on Renal Cell Carcinoma 40
Apr 16, 2014: Cleveland BioLabs Announces the Successful Completion of a Phase 1 Study of CBL0102 40
Apr 07, 2014: Curis and Debiopharm Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014 40
Dec 05, 2013: Immunicum Reports Positive Phase I/II-Data for the Therapeutic Cancer Vaccine INTUVAX in the Treatment of Kidney Cancer 41
Nov 07, 2013: Celldex Therapeutics’ CDX-1127 Well Tolerated and Demonstrates Anti-Tumor Activity in Phase 1 Dose-Escalation Study 41
Sep 26, 2013: Combinability of CRLX101 and Avastin Established in Clinical Trial in Renal Cell Carcinoma 42
Clinical Trial Profiles 44
Clinical Trial Overview of Top Companies 44
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Bayer AG 54
Clinical Trial Overview of Bayer AG 54
GlaxoSmithKline plc 58
Clinical Trial Overview of GlaxoSmithKline plc 58
F. Hoffmann-La Roche Ltd. 61
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 61
Bristol-Myers Squibb Company 64
Clinical Trial Overview of Bristol-Myers Squibb Company 64
AstraZeneca PLC 66
Clinical Trial Overview of AstraZeneca PLC 66
Amgen Inc. 67
Clinical Trial Overview of Amgen Inc. 67
Eli Lilly and Company 68
Clinical Trial Overview of Eli Lilly and Company 68
AVEO Pharmaceuticals, Inc. 69
Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 69
Clinical Trial Overview of Top Institutes / Government 70
National Cancer Institute 70
Clinical Trial Overview of National Cancer Institute 70
The University of Texas M. D. Anderson Cancer Center 81
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 81
Memorial Sloan Kettering Cancer Center 83
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 83
European Organization for Research and Treatment of Cancer 85
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 85
UCLA’s Jonsson Comprehensive Cancer Center 86
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 86
Roswell Park Cancer Institute 87
Clinical Trial Overview of Roswell Park Cancer Institute 87
Case Comprehensive Cancer Center 88
Clinical Trial Overview of Case Comprehensive Cancer Center 88
Radboud University 89
Clinical Trial Overview of Radboud University 89
The University of Chicago 90
Clinical Trial Overview of The University of Chicago 90
Beth Israel Deaconess Medical Center 91
Clinical Trial Overview of Beth Israel Deaconess Medical Center 91
Five Key Clinical Profiles 92
Appendix 212
Abbreviations 212
Definitions 212
Research Methodology 213
Secondary Research 213
About GlobalData 214
Contact Us 214
Disclaimer 214
Source 215


【レポート販売概要】

■ タイトル:腎細胞がん:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月24日
■ 調査会社:GlobalData
■ 商品コード:GDHC2100CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。